Genevieve H Wills Selected Research

Optic Nerve Diseases (Optic Neuropathy)

1/2022

Bedaquiline-Pretomanid-Linezolid Regimens for Drug-Resistant Tuberculosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Genevieve H Wills Research Topics

Disease

3	Tuberculosis (Tuberculoses) 01/2022 - 11/2018
2	Peripheral Nervous System Diseases (PNS Diseases) 01/2022 - 01/2020
2	Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis) 01/2022 - 01/2020
1	Optic Nerve Diseases (Optic Neuropathy) 01/2022
1	Extensively Drug-Resistant Tuberculosis 01/2020
1	Malignant Pleural Effusion 01/2018
1	Dyspnea (Shortness of Breath) 01/2018

Drug/Important Bio-Agent (IBA)

2	bedaquiline (R207910)IBA 01/2022 - 01/2020
2	Linezolid (Zyvox)FDA Link 01/2022 - 01/2020
2	pretomanidIBA 01/2022 - 01/2020
1	AminoglycosidesIBA 01/2022
1	FluoroquinolonesIBA 01/2022
1	Rifampin (Rifampicin)FDA LinkGeneric 01/2022
1	Drug CombinationsIBA 01/2020
1	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 01/2018

Therapy/Procedure

1	Duration of Therapy 01/2022
1	Therapeutics 01/2020
1	Drug Tapering 01/2020
1	Drug Therapy (Chemotherapy) 11/2018
1	Pleurodesis 01/2018